Medicare’s recent move to cover the weight-loss drug Wegovy for some recipients with heart disease risk could drive up the cost of monthly premiums for millions of enrollees.
Related Posts
How this longtime apothecary in NYC looks toward the future
For four generations, the Ginsberg family has been